Dr Catriona Manville is a Senior Analyst at RAND Europe. She has been extensively involved in the evaluation of the impact element of REF2104, looking at the submission and assessment process. She has a particular interest in understanding and articulating the impact of research outside of academia and exploring how impact can be measured. In 2013, Catriona was part of the RAND Europe team evaluating the Australian Impact Trial (EIA). Catriona is currently seconded part time to the National Institute for Health Research (NIHR) working on business intelligence. Whilst at RAND, Catriona has also undertaken research, policy analysis and evaluation studies for clients in a variety of sectors including the European Commission and Parliament, higher education institutions, pharmaceutical industry, public private partnerships, and public health.
